Qilian International Holding Group Limited
NASDAQ: QLI0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Chen Xin
- Employees
- 298
- Headquarters
- Jiuquan, China
- IPO year
- 2021
- Market cap
- $38.7M
- Website
- https://www.qlsyy.net
Loading QLI…
Loading profile data…Frequently asked questions about QLI
What does Qilian International Holding Group Limited (QLI) do?
Qilian International Holding Group Limited (QLI), founded in 2019 and headquartered in Jiuquan, People's Republic of China, focuses on the research, development, and production of active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMDs), and a variety of other products. The company's diverse offerings include li...
Where does QLI trade?
Qilian International Holding Group Limited (QLI) trades on the NASDAQ Global Market.
What sector is QLI in?
Qilian International Holding Group Limited (QLI) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Qilian International Holding Group Limited?
Chen Xin is the chief executive officer of Qilian International Holding Group Limited (QLI).
Where is Qilian International Holding Group Limited headquartered?
Qilian International Holding Group Limited is headquartered in China.
Does QLI pay a dividend?
Qilian International Holding Group Limited (QLI) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did QLI go public?
Qilian International Holding Group Limited (QLI) completed its initial public offering in 2021.